ACN vs EBS
Accenture plc (ACN) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Accenture plc (ACN) is a information technology services company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ACN revenue for 2025-08-31 was $17.60B. Net income was $1.41B. Revenue was down 0.7% from 2025-05-31 to 2025-08-31. ACN currently screens at market cap $186.16B and trailing P/E 23.8.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
ACN currently screens at market cap $186.16B and trailing P/E 23.8. EBS currently screens at market cap $416.4M.
Not investment advice. Open the ACN and EBS stock pages for the full models.
Not investment advice.